Stay updated with breaking news from Patrickj Haley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A number of research firms have changed their ratings and price targets for Exelixis (NASDAQ: EXEL): 4/14/2023 – Exelixis was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating. 4/12/2023 – Exelixis had its price target lowered by analysts at Morgan Stanley from $22.00 to $21.00. They now have an “equal […]
Exelixis (NASDAQ:EXEL – Get Rating) had its target price trimmed by Morgan Stanley from $22.00 to $21.00 in a research report released on Wednesday morning, The Fly reports. The brokerage currently has an equal weight rating on the biotechnology company’s stock. EXEL has been the topic of a number of other reports. Wells Fargo & […]
StockNews.com downgraded shares of Exelixis (NASDAQ:EXEL – Get Rating) from a buy rating to a hold rating in a research report report published on Thursday morning. Other equities analysts have also recently issued reports about the company. Truist Financial reduced their target price on Exelixis from $35.00 to $32.00 in a research note on Friday, […]
Stephens Investment Management Group LLC trimmed its stake in Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,047,250 shares of the biotechnology company’s stock after selling 25,961 shares during the quarter. Exelixis accounts for 1.1% […]
StockNews.com upgraded shares of Exelixis (NASDAQ:EXEL – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday. EXEL has been the subject of several other reports. EF Hutton Acquisition Co. I reiterated a buy rating and set a $24.00 target price on shares of Exelixis in a […]